MedPath

Salsalate

Salsalate Tablets, USP500 mg and 750 mgRx Only

Approved
Approval ID

8bc31246-b962-46fd-b235-26c34b1b0781

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Feb 27, 2023

Manufacturers
FDA

Bryant Ranch Prepack

DUNS: 171714327

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Salsalate

PRODUCT DETAILS

NDC Product Code63629-9248
Application NumberN/A
Marketing CategoryN/A
Route of AdministrationORAL
Effective DateAugust 10, 2020
Generic NameSalsalate

INGREDIENTS (9)

SODIUM STARCH GLYCOLATE TYPE AInactive
Code: H8AV0SQX4D
Classification: IACT
STEARIC ACIDInactive
Code: 4ELV7Z65AP
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT
TRIACETINInactive
Code: XHX3C3X673
Classification: IACT
SALSALATEActive
Quantity: 500 mg in 1 1
Code: V9MO595C9I
Classification: ACTIB
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
D&C YELLOW NO. 10Inactive
Code: 35SW5USQ3G
Classification: IACT
HYPROMELLOSE, UNSPECIFIEDInactive
Code: 3NXW29V3WO
Classification: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61U
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Salsalate - FDA Drug Approval Details